Screener
Ocular Therapeutix OCUL Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total assets | $732,529 | $808,057 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $8,026 | $4,154 |
| Accrued expenses and other current liabilities | 36,487 | 43,835 |
| Operating lease liabilities | 3,170 | 2,817 |
| Total current liabilities | 47,683 | 50,806 |
| Other liabilities: |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's accounts payable?
- Ocular Therapeutix (OCUL) reported accounts payable of $8.03M in Q1 2026.
- How has Ocular Therapeutix's accounts payable changed year-over-year?
- Ocular Therapeutix's accounts payable increased by 73.5% year-over-year, from $4.63M to $8.03M.
- What is the long-term trend for Ocular Therapeutix's accounts payable?
- Over 5 years (2020 to 2025), Ocular Therapeutix's accounts payable has grown at a 8.9% compound annual growth rate (CAGR), from $2.71M to $4.15M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Ocular Therapeutix's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude